Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Assets (2016 - 2025)

Historic Assets for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to $49.3 million.

  • Fennec Pharmaceuticals' Assets fell 1639.48% to $49.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.3 million, marking a year-over-year decrease of 1639.48%. This contributed to the annual value of $44.9 million for FY2024, which is 6730.94% up from last year.
  • Latest data reveals that Fennec Pharmaceuticals reported Assets of $49.3 million as of Q3 2025, which was down 1639.48% from $44.9 million recorded in Q2 2025.
  • Fennec Pharmaceuticals' 5-year Assets high stood at $69.2 million for Q1 2024, and its period low was $15.6 million during Q2 2022.
  • In the last 5 years, Fennec Pharmaceuticals' Assets had a median value of $28.0 million in 2021 and averaged $35.5 million.
  • As far as peak fluctuations go, Fennec Pharmaceuticals' Assets crashed by 4462.74% in 2022, and later surged by 22495.24% in 2024.
  • Over the past 5 years, Fennec Pharmaceuticals' Assets (Quarter) stood at $26.0 million in 2021, then increased by 3.56% to $26.9 million in 2022, then fell by 0.28% to $26.9 million in 2023, then soared by 67.31% to $44.9 million in 2024, then grew by 9.6% to $49.3 million in 2025.
  • Its Assets was $49.3 million in Q3 2025, compared to $44.9 million in Q2 2025 and $46.4 million in Q1 2025.